Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction

Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we inve...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 48; no. 2; pp. 225 - 231
Main Authors Matsui, Hiromitsu, Shimosawa, Tatsuo, Uetake, Yuzaburo, Wang, Hong, Ogura, Sayoko, Kaneko, Tomoyo, Liu, Jing, Ando, Katsuyuki, Fujita, Toshiro
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.08.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week–old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects.
AbstractList Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week–old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects.
Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week-old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects.Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal relaxation, relatively early functional cardiac alteration in hypertensive subjects, has not been fully elucidated. In the present study, we investigated the effect of potassium against salt-induced cardiac dysfunction and the involved mechanism. Seven- to 8-week-old Dahl salt sensitive rats were fed normal diet (0.3% NaCl) or high-salt diet (8% NaCl) with or without high potassium (8% KCl) for 8 weeks. Left ventricular relaxation was evaluated by the deceleration time of early diastolic filling obtained from Doppler transmitral inflow, the slope of the pressure curve, and the time constant at the isovolumic relaxation phase. High-salt loading induced a significant elevation of blood pressure and impaired left ventricular relaxation, accompanied by augmentation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activity in the cardiac tissue, measured by the lucigenin chemiluminescence method. Blood pressure lowering by hydralazine could not ameliorate NADPH oxidase activity and resulted in no improvement of left ventricular relaxation. Interestingly, although the blood pressure remained high, potassium supplementation as well as treatment with 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl, a superoxide dismutase mimetic, not only reduced the elevated NADPH oxidase activity but also improved the left ventricular relaxation. In conclusion, a high-potassium diet has a potent protective effect on left ventricular active relaxation independent of blood pressure, partly through the inhibition of cardiac NADPH oxidase activity. Sufficient potassium supplementation might be an attractive strategy for cardiac protection, especially in the salt-sensitive hypertensive subjects.
Author Shimosawa, Tatsuo
Ando, Katsuyuki
Matsui, Hiromitsu
Liu, Jing
Ogura, Sayoko
Fujita, Toshiro
Wang, Hong
Kaneko, Tomoyo
Uetake, Yuzaburo
AuthorAffiliation From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan
AuthorAffiliation_xml – name: From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan
Author_xml – sequence: 1
  givenname: Hiromitsu
  surname: Matsui
  fullname: Matsui, Hiromitsu
  organization: From the Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan
– sequence: 2
  givenname: Tatsuo
  surname: Shimosawa
  fullname: Shimosawa, Tatsuo
– sequence: 3
  givenname: Yuzaburo
  surname: Uetake
  fullname: Uetake, Yuzaburo
– sequence: 4
  givenname: Hong
  surname: Wang
  fullname: Wang, Hong
– sequence: 5
  givenname: Sayoko
  surname: Ogura
  fullname: Ogura, Sayoko
– sequence: 6
  givenname: Tomoyo
  surname: Kaneko
  fullname: Kaneko, Tomoyo
– sequence: 7
  givenname: Jing
  surname: Liu
  fullname: Liu, Jing
– sequence: 8
  givenname: Katsuyuki
  surname: Ando
  fullname: Ando, Katsuyuki
– sequence: 9
  givenname: Toshiro
  surname: Fujita
  fullname: Fujita, Toshiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16818802$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1uEzEUhS1URNPCKyCLBbsZbI_HnumKKBSCVKkRPwJWlse-0xgm49T2ULLi1XGSokqs8Ma-1neOdM85QyejHwGhF5SUlAr6itBy-W1VknxYxQSVJW8qyUrTPUIzWjNe8FpUJ2hGaMuLltKvp-gsxu-EUM65fIJOqWho0xA2Q79XwScwyf0EfNn3-YV9j1c-6RjdtMHzG-3GmHBaA17uthASjHEPL3SwThv8Zhf7acwGfrzA8xi9cXo_4C8urfEH0Efv61-7Gxjxxy0YBzH_2-mgeYoe93qI8Oz-Pkef315-WiyLq-t37xfzq8JwUvGCEca11ZqzrrZS8labribQyE53UuZdWKMrLUBaq6nlnbaMCdMSyzomKllX5-jl0Xcb_O0EMamNiwaGQY_gp6hEI-pWiiqDz-_BqduAVdvgNjrs1N_IMnBxBEzwMQboHxCi9v0oQlXuRz30ow79KNNl8et_xMalQ14paDf8nwU_Wtz5IUGIP4bpDoJagx7S-qDgTDQ5MSJIk6eC7Huv_gDbkqng
CitedBy_id crossref_primary_10_1007_s10157_010_0350_8
crossref_primary_10_1016_j_mehy_2018_08_001
crossref_primary_10_3945_ajcn_111_013094
crossref_primary_10_1016_j_toxrep_2025_101936
crossref_primary_10_1371_journal_pone_0232413
crossref_primary_10_2169_naika_97_37a
crossref_primary_10_1007_s11906_013_0358_z
crossref_primary_10_1007_s10554_023_02914_x
crossref_primary_10_3389_fphar_2021_756671
crossref_primary_10_3109_10715762_2014_991724
crossref_primary_10_1016_j_mencom_2007_06_010
crossref_primary_10_1186_s40659_021_00365_z
crossref_primary_10_1016_j_semnephrol_2013_04_008
crossref_primary_10_2169_naika_96_1827
crossref_primary_10_1159_000472259
crossref_primary_10_3109_07853890_2012_671538
crossref_primary_10_1002_bmc_970
crossref_primary_10_1016_j_neuro_2023_09_007
crossref_primary_10_1016_j_mvr_2012_09_005
crossref_primary_10_1177_0148607113491781
crossref_primary_10_1016_j_freeradbiomed_2009_04_030
crossref_primary_10_1038_hr_2011_63
crossref_primary_10_1093_gerona_63_10_1034
crossref_primary_10_3109_10641960903254521
crossref_primary_10_1111_jch_13207
crossref_primary_10_1017_jns_2013_4
crossref_primary_10_1080_13813450802535978
crossref_primary_10_2169_naika_96_46a
crossref_primary_10_1097_JCMA_0000000000000103
crossref_primary_10_1038_hr_2016_127
crossref_primary_10_1253_jjcsc_19_1_3
crossref_primary_10_1016_j_mehy_2011_09_028
crossref_primary_10_1093_ajh_hpy101
crossref_primary_10_1007_s00395_009_0014_6
crossref_primary_10_1152_ajprenal_00123_2014
crossref_primary_10_1038_hr_2010_46
crossref_primary_10_4162_nrp_2014_8_4_417
crossref_primary_10_1186_s12944_015_0002_9
crossref_primary_10_1097_HJH_0b013e328300a232
crossref_primary_10_31083_j_fbs1504014
crossref_primary_10_3390_nu12051206
crossref_primary_10_1080_07315724_2008_10719740
crossref_primary_10_1093_eurheartj_ehac313
crossref_primary_10_1016_j_foodchem_2023_137408
crossref_primary_10_24018_ejmed_2023_5_4_1755
crossref_primary_10_3109_08037051_2011_649537
crossref_primary_10_1590_S1677_55382012000200011
crossref_primary_10_2169_naika_97_1979
crossref_primary_10_1111_j_1440_1681_2011_05510_x
crossref_primary_10_1146_annurev_physiol_010908_163241
crossref_primary_10_31083_j_jin2204098
crossref_primary_10_1038_ajh_2007_9
crossref_primary_10_1111_j_1440_1681_2009_05198_x
crossref_primary_10_1111_j_1748_1716_2010_02248_x
crossref_primary_10_3317_jraas_2006_029
crossref_primary_10_1186_s42826_023_00179_y
Cites_doi 10.1038/nm1119
10.1074/jbc.M102124200
10.1152/ajpcell.00230.2003
10.1164/ajrccm.154.4.8887607
10.1161/circ.62.4.7408148
10.1016/S0735-1097(01)01230-X
10.1161/01.CIR.58.6.1072
10.1161/01.hyp.0000032031.30374.32
10.1016/S0735-1097(03)00471-6
10.1001/jama.289.2.194
10.1016/S0022-2828(03)00080-4
10.1161/01.hyp.6.2.184
10.1007/978-1-4615-5385-4_10
10.1161/circ.104.24.2967
10.1016/0735-1097(91)90774-4
10.1097/00004872-200018010-00016
10.1161/hyp.30.6.1628
10.1016/S0735-1097(98)00101-6
10.1152/ajpheart.00549.2001
10.1161/circ.69.3.6362906
10.1172/JCI108522
10.1161/01.atv.21.4.489
10.1161/01.hyp.0000118017.02160.fa
10.1152/ajpheart.00047.2004
10.1210/jc.2004-0305
10.1161/01.hyp.0000178572.63064.73
10.1097/00005344-200106000-00010
10.1038/sj.jhh.1000893
10.1161/circ.97.16.1536
10.1159/000086411
10.1016/j.amjhyper.2003.08.003
10.1161/01.hyp.0000138070.47616.9d
10.1056/NEJMoa032566
10.1161/01.hyp.0000094557.36656.d0
10.1161/01.cir.0000091084.46500.bb
10.1161/01.RES.22.1.11
10.1161/01.hyp.24.1.77
10.1161/res.85.4.357
10.1038/ki.1983.220
10.1056/NEJM200101043440101
10.1161/circ.101.15.1854
10.1161/01.hyp.6.4.475
10.1016/1071-9164(95)90024-1
10.1161/01.cir.0000018605.14470.dd
ContentType Journal Article
Copyright 2006 American Heart Association, Inc.
Copyright_xml – notice: 2006 American Heart Association, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/01.HYP.0000232617.48372.cb
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 231
ExternalDocumentID 16818802
10_1161_01_HYP_0000232617_48372_cb
00004268-200608000-00014
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
18M
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YOC
YYM
YYP
ZFV
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
RHF
7X8
ID FETCH-LOGICAL-c4034-2024adaa42b5d7749acb50e87bab7718828a3a6e7dda1d4bad226c90d2b263753
ISSN 0194-911X
1524-4563
IngestDate Fri Jul 11 00:48:43 EDT 2025
Wed Feb 19 01:46:23 EST 2025
Thu Apr 24 23:09:11 EDT 2025
Tue Jul 01 04:30:40 EDT 2025
Fri May 16 03:51:29 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4034-2024adaa42b5d7749acb50e87bab7718828a3a6e7dda1d4bad226c90d2b263753
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16818802
PQID 68659763
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_68659763
pubmed_primary_16818802
crossref_primary_10_1161_01_HYP_0000232617_48372_cb
crossref_citationtrail_10_1161_01_HYP_0000232617_48372_cb
wolterskluwer_health_00004268-200608000-00014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-August
2006-08-00
2006-Aug
20060801
PublicationDateYYYYMMDD 2006-08-01
PublicationDate_xml – month: 08
  year: 2006
  text: 2006-August
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 2006
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
16818803 - Hypertension. 2006 Aug;48(2):201-2
References_xml – ident: e_1_3_2_27_2
  doi: 10.1038/nm1119
– ident: e_1_3_2_32_2
  doi: 10.1074/jbc.M102124200
– ident: e_1_3_2_34_2
  doi: 10.1152/ajpcell.00230.2003
– ident: e_1_3_2_39_2
  doi: 10.1164/ajrccm.154.4.8887607
– ident: e_1_3_2_22_2
  doi: 10.1161/circ.62.4.7408148
– ident: e_1_3_2_6_2
  doi: 10.1016/S0735-1097(01)01230-X
– ident: e_1_3_2_21_2
  doi: 10.1161/01.CIR.58.6.1072
– ident: e_1_3_2_26_2
  doi: 10.1161/01.hyp.0000032031.30374.32
– ident: e_1_3_2_31_2
  doi: 10.1016/S0735-1097(03)00471-6
– ident: e_1_3_2_7_2
  doi: 10.1001/jama.289.2.194
– ident: e_1_3_2_28_2
  doi: 10.1016/S0022-2828(03)00080-4
– ident: e_1_3_2_37_2
  doi: 10.1161/01.hyp.6.2.184
– ident: e_1_3_2_4_2
  doi: 10.1007/978-1-4615-5385-4_10
– ident: e_1_3_2_12_2
  doi: 10.1161/circ.104.24.2967
– ident: e_1_3_2_15_2
  doi: 10.1016/0735-1097(91)90774-4
– ident: e_1_3_2_17_2
  doi: 10.1097/00004872-200018010-00016
– ident: e_1_3_2_18_2
  doi: 10.1161/hyp.30.6.1628
– ident: e_1_3_2_9_2
  doi: 10.1016/S0735-1097(98)00101-6
– ident: e_1_3_2_30_2
  doi: 10.1152/ajpheart.00549.2001
– ident: e_1_3_2_36_2
  doi: 10.1161/circ.69.3.6362906
– ident: e_1_3_2_23_2
  doi: 10.1172/JCI108522
– ident: e_1_3_2_33_2
  doi: 10.1161/01.atv.21.4.489
– ident: e_1_3_2_44_2
  doi: 10.1161/01.hyp.0000118017.02160.fa
– ident: e_1_3_2_24_2
  doi: 10.1152/ajpheart.00047.2004
– ident: e_1_3_2_40_2
  doi: 10.1210/jc.2004-0305
– ident: e_1_3_2_14_2
  doi: 10.1161/01.hyp.0000178572.63064.73
– ident: e_1_3_2_20_2
  doi: 10.1097/00005344-200106000-00010
– ident: e_1_3_2_3_2
  doi: 10.1038/sj.jhh.1000893
– ident: e_1_3_2_10_2
  doi: 10.1161/circ.97.16.1536
– ident: e_1_3_2_41_2
  doi: 10.1159/000086411
– ident: e_1_3_2_19_2
  doi: 10.1016/j.amjhyper.2003.08.003
– ident: e_1_3_2_38_2
  doi: 10.1161/01.hyp.0000138070.47616.9d
– ident: e_1_3_2_5_2
  doi: 10.1056/NEJMoa032566
– ident: e_1_3_2_8_2
  doi: 10.1161/01.hyp.0000094557.36656.d0
– ident: e_1_3_2_25_2
  doi: 10.1161/01.cir.0000091084.46500.bb
– ident: e_1_3_2_2_2
  doi: 10.1161/01.RES.22.1.11
– ident: e_1_3_2_13_2
  doi: 10.1161/01.hyp.24.1.77
– ident: e_1_3_2_29_2
  doi: 10.1161/res.85.4.357
– ident: e_1_3_2_35_2
  doi: 10.1038/ki.1983.220
– ident: e_1_3_2_42_2
  doi: 10.1056/NEJM200101043440101
– ident: e_1_3_2_11_2
  doi: 10.1161/circ.101.15.1854
– ident: e_1_3_2_1_2
  doi: 10.1161/01.hyp.6.4.475
– ident: e_1_3_2_16_2
  doi: 10.1016/1071-9164(95)90024-1
– ident: e_1_3_2_43_2
  doi: 10.1161/01.cir.0000018605.14470.dd
– reference: 16818803 - Hypertension. 2006 Aug;48(2):201-2
SSID ssj0014447
Score 2.1542542
Snippet Potassium supplementation has a potent protective effect against cardiovascular disease, but the precise mechanism of it against left ventricular abnormal...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 225
SubjectTerms Animals
Blood Pressure - drug effects
Body Weight - drug effects
Dietary Supplements
Disease Models, Animal
Echocardiography
Heart Ventricles - metabolism
Heart Ventricles - pathology
Heart Ventricles - physiopathology
Hypertension - complications
Hypertension - diet therapy
Hypertension - physiopathology
Male
NADPH Oxidases - metabolism
Organ Size - drug effects
Potassium Chloride - administration & dosage
Potassium, Dietary - therapeutic use
Rats
Rats, Inbred Dahl
Reactive Oxygen Species - metabolism
Sodium Chloride, Dietary
Ventricular Dysfunction, Left - complications
Ventricular Dysfunction, Left - physiopathology
Ventricular Dysfunction, Left - prevention & control
Title Protective Effect of Potassium Against the Hypertensive Cardiac Dysfunction: Association With Reactive Oxygen Species Reduction
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-200608000-00014
https://www.ncbi.nlm.nih.gov/pubmed/16818802
https://www.proquest.com/docview/68659763
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAIIW6DcvUDb1VK4rpOwhuCTRWsY0it6J4s3woV0KA21S4v_BF-LMeXXKYNMXiJKqeOo3xfjs_nnHOM0AspiZKZSCKTgVyF-Xoe5SI1kVIENJCZZ1LZROHxPhtN6bvZcNbp_GpFLW1K2VenF-aV_A-q0Aa42izZf0C2vig0wG_AF46AMBwvhfGBL7Jgg398XIaLXy5KcIgXNuj4M8j-tUtW7H0BvbmqotWVo4Xq6ZO1ndeq-A7RQOXXZ8Gh9Fcvjk_gJno2LROUNbRrX3S27dqO6hEcobK3doneByGZ434vydO8tewwFuV643fMXqyK74vSb8Diq0UCf9biyLm1E_u_ojo1NaXw0USHm1MBfKjPfArr3qMiTMWtlYysWskIxpfQCBw6b_DMBW3BYtOsxUzSNr8-ifr8tMASl-rQHx0euIqV4EeC69a35fRJX8lmMqwCAPY_8N3p3h6f7MwmV9BVAiLEWtH3H5tvVJS67evqOwwlbWGsl38e6az7c07T3EA3jwobJrH-6rIkWr7O5Da6FUQKfu0Zdwd1zPIuujYOYRj30M-GeNgTDxdzXBMPB-JhIB5uEw8H4uEW8V7hFu2wpR2uaIc97XCgHa5pdx9Nd3cmb0ZR2MkjUjQeUHhpCRVaCErkUIPgyIWSw9hkqRQyBe8IZL8YCGZSrUWiqRQaVIHKY00kYQNQ1Ntoa1kszUOETcq0YTrWimU0ESbXKXSXMmNqSObxsIvy6gFzFcrc291WvnEnd1nC44QDOLwBhztwuJJdNKj7_vDFXi7V63mFIwfbbD-4iaUpNmvOMgZ6nQ266IGHt7kqy2whRNJF0Rm8uc9-dsOA7-zMHbOizpV_SOijv471GF1v3q0naKtcbcxT8JtL-czR9zcHpcQr
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protective+effect+of+potassium+against+the+hypertensive+cardiac+dysfunction%3A+association+with+reactive+oxygen+species+reduction&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Matsui%2C+Hiromitsu&rft.au=Shimosawa%2C+Tatsuo&rft.au=Uetake%2C+Yuzaburo&rft.au=Wang%2C+Hong&rft.date=2006-08-01&rft.issn=1524-4563&rft.eissn=1524-4563&rft.volume=48&rft.issue=2&rft.spage=225&rft_id=info:doi/10.1161%2F01.HYP.0000232617.48372.cb&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon